Pier Capital LLC purchased a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 219,827 shares of the company's stock, valued at approximately $4,040,000. Pier Capital LLC owned approximately 0.15% of Ardent Health Partners at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the company. Jane Street Group LLC acquired a new position in Ardent Health Partners in the third quarter valued at $567,000. Wellington Management Group LLP purchased a new stake in Ardent Health Partners in the 3rd quarter valued at about $28,724,000. Soros Fund Management LLC acquired a new position in shares of Ardent Health Partners during the 3rd quarter valued at about $4,595,000. State Street Corp purchased a new position in shares of Ardent Health Partners during the 3rd quarter worth about $1,977,000. Finally, Systematic Financial Management LP acquired a new stake in shares of Ardent Health Partners in the third quarter worth approximately $595,000.
Ardent Health Partners Stock Performance
Shares of Ardent Health Partners stock traded up $0.65 on Friday, hitting $16.65. 282,817 shares of the company's stock traded hands, compared to its average volume of 232,256. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The business's 50-day simple moving average is $17.58. Ardent Health Partners, LLC has a 52-week low of $14.57 and a 52-week high of $20.72.
Wall Street Analyst Weigh In
A number of research firms have weighed in on ARDT. Royal Bank of Canada reaffirmed an "outperform" rating and set a $23.00 price target on shares of Ardent Health Partners in a research note on Thursday, November 14th. Loop Capital began coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They set a "buy" rating and a $18.00 price target on the stock. Morgan Stanley began coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They issued an "overweight" rating and a $27.00 price objective for the company. Leerink Partnrs upgraded shares of Ardent Health Partners to a "strong-buy" rating in a report on Monday, August 12th. Finally, KeyCorp initiated coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They set an "overweight" rating and a $24.00 price target for the company. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Buy" and a consensus price target of $21.82.
Check Out Our Latest Report on ARDT
About Ardent Health Partners
(
Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
See Also
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
